Preferred Label : nemolizumab;

CISMeF synonym : CIM331;

MeSH hyponym : CIM-331;

UNII : GN465U8B72;

Détails


Consulter ci-dessous une sélection des principales ressources :

Vous pouvez consulter :


https://www.has-sante.fr/jcms/p_3636353/fr/nemluvio-nemolizumab-prurigo-nodulaire-chez-l-adulte
2025
false
false
false
France
nemolizumab
insurance, health, reimbursement
treatment outcome
Prurigo nodularis (disorder)
antibodies, monoclonal, humanized
injections, subcutaneous
evaluation of the transparency committee
adult
nemolizumab
prurigo

---
https://www.ema.europa.eu/en/medicines/human/EPAR/nemluvio
2025
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
nemolizumab
nemolizumab
drug approval
europe
nemolizumab
adult
adolescent
dermatitis, atopic
antibodies, monoclonal, humanized
antibodies, monoclonal, humanized
Prurigo nodularis (disorder)
injections, subcutaneous
product surveillance, postmarketing
drug interactions
pregnancy
breast feeding
IL31RA protein, human
receptors, interleukin
drug evaluation, preclinical

---
Nous contacter.
27/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.